Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Mallon Insider Profile

4 Followers

Mark Mallon, CEO, Director at NeoGenomics, holds 368.05K shares in NeoGenomics (Ticker: NEO), holds 470.61K shares in Ironwood Pharma (Ticker: IRWD).

Mark Mallon's Trading History

NEO
NeoGenomics
Mar 03, 2022CEO, DirectorUninformative Buy―$5.90M
IRWD
Ironwood Pharma
Mar 02, 2021CEO, DirectorUninformative Sell279.45K$2.27M

You May Also Like

Mark Mallon insider profile FAQ

What stocks does Mark Mallon hold?
Mark Mallon holds: NEO, IRWD stocks.
What is Mark Mallon's role in NeoGenomics?
Mark Mallon's role in NeoGenomics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.